PROactive study

Lancet. 2006 Jan 7;367(9504):25-6; author reply 26-7. doi: 10.1016/S0140-6736(06)67914-2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Heart Failure / prevention & control
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Models, Cardiovascular*
  • Pioglitazone
  • Risk Factors
  • Thiazolidinediones / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Pioglitazone